| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.41 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.17 | 0.6 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.079 | 0.8 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.062 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.23 | 0.0003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.13 | 0.06 |